| Previous close | 604.53 |
| Open | 604.52 |
| Bid | 537.00 |
| Ask | 544.75 |
| Strike | 350.00 |
| Expiry date | 2025-01-17 |
| Day's range | 604.52 - 604.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 209 |
ZacksEli Lilly (LLY) Rises But Trails Market: What Investors Should Know
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
ZacksPharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
Yahoo FinanceWhat end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?
© 2024 Yahoo. All rights reserved.